Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
about
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics.Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic TreatmentLow prevalence of lipid metabolism abnormalities in APOE ε2-genotype and male patients 60 years or older with schizophrenia.Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics.The neuroprotective effect of cornus MAS on brain tissue of Wistar rats.
P2860
Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reduced serum paraoxonase 1 (P ...... olanzapine but not quetiapine
@en
Reduced serum paraoxonase 1
@nl
type
label
Reduced serum paraoxonase 1 (P ...... olanzapine but not quetiapine
@en
Reduced serum paraoxonase 1
@nl
prefLabel
Reduced serum paraoxonase 1 (P ...... olanzapine but not quetiapine
@en
Reduced serum paraoxonase 1
@nl
P2093
P2860
P356
P1476
Reduced serum paraoxonase 1 (P ...... olanzapine but not quetiapine
@en
P2093
Cüneyt Unsal
Murat Kuloglu
Neslihan Albayrak
Yakup Albayrak
P2860
P304
P356
10.2147/NDT.S52463
P407
P50
P577
2013-10-11T00:00:00Z